95556-7
LaboratoryAdrenal cancer risk assessment and urine steroid fractions panel
Definition
A risk assessment based on patient clinical data combined with biochemical steroid results to assess the probability of a malignant adrenal cortical carcinoma (ACC) or other malignancy (e.g. sarcoma, lymphoma) versus the probability of a benign mass (e.g. adenoma, myelolipoma, cyst). Clinical biomarkers may include age at diagnosis, gender, mode of discovery, hormonal status (e.g. overproduction), tumor diameter, and density of the tumor by CT.
LOINC 6-Axis Classification
Component
Adrenal cancer risk assessment & urine steroid fractions panel
Property
-
Time Aspect
-
System
^Patient
Scale Type
-
Method Type
N/A
Details
Class
PANEL.CHEM
Order/Observation
Order
Short Name
Adrenal ca risk assess+ur steroid Pnl
Display Name
Adrenal cancer risk assessment and urine steroid fractions panel
Related Names
Frequently Asked Questions
What is LOINC code 95556-7?
LOINC code 95556-7 identifies "Adrenal cancer risk assessment and urine steroid fractions panel". A risk assessment based on patient clinical data combined with biochemical steroid results to assess the probability of a malignant adrenal cortical carcinoma (ACC) or other malignancy (e.g. sarcoma, lymphoma) versus the probability of a benign mass (e.g. adenoma, myelolipoma, cyst). Clinical biomarkers may include age at diagnosis, gender, mode of discovery, hormonal status (e.g. overproduction), tumor diameter, and density of the tumor by CT.
What does 95556-7 measure?
This code measures Adrenal cancer risk assessment & urine steroid fractions panel in ^Patient. It belongs to the PANEL.CHEM class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.